Advertisement
Abstract| Volume 87, ISSUE 9, SUPPLEMENT , S128, May 01, 2020

One-Year Clinical Outcomes Following Theta Burst Stimulation for Posttraumatic Stress Disorder

      Theta burst transcranial magnetic stimulation (TBS) is a potential new treatment for posttraumatic stress disorder (PTSD). We reported active intermittent TBS (iTBS) was associated with superior clinical outcomes in a sample (N=50) of Veterans with PTSD. In that study, participants received 2-weeks of active or sham iTBS, followed by 2-weeks unblinded active iTBS. Superior results were observed with greater exposure to active iTBS for up to 1-month, which raised the question of whether observed effects persisted longer-term.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect